UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000029202
Receipt No. R000033136
Official scientific title of the study Study on effects of functional fermented tea leaf powder, MarugotoHakkocha, made from green tea leaves and loquat leaves on postprandial blood glucose levels
Date of disclosure of the study information 2017/09/20
Last modified on 2018/03/22 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study on effects of functional fermented tea leaf powder, MarugotoHakkocha, made from green tea leaves and loquat leaves on postprandial blood glucose levels
Title of the study (Brief title) Effects of fermented tea leaf powder on postprandial blood glucose levels
Region
Japan

Condition
Condition Postprandial huperglycemia
Classification by specialty
Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effect of a fermented tea leaf powder on postprandial hyperglycemia
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Postprandial blood glucose level,Blood insulin concentration
Key secondary outcomes Body weight,Blood pressure,Serum LDL-cholesterol,Serum HDL-cholesterol,Serum triglyceride,White blood cell count,Red blood cell count,Hemoglobin,Hematocrit,Platelet count,Total protein,Albumin,GOT,GPT,LDH,Total bilirubin,ALP,Gamma GTP,Urea nitrogen,Creatinine,Uric acid,HbA1c,Urinary sugar, Urinary protein

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 The subjects ingested a single intake of the active meal, and injested a single intake of the placebo meal after 7 days or 14 days.
Interventions/Control_2 The subjects ingested a single intake of the active meal, and injested a single intake of the placebo meal after 7 days or 14 days.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
70 years-old >
Gender Male and Female
Key inclusion criteria 1) Healthy male and female between 20 and 70 years old
2) Those who are liable to rise in postprandial blood glucose levels during screening tests
3) Individuals who can refrain from drinking and eating during the test period
4) Individuals who understand the purpose and contents of the experiment
Key exclusion criteria 1)Individuals taking drugs, supplements and healthy foods which affect the blood glucose levels
2)Those who can not stop taking supplements or health foods that may affect blood glucose levels during the test period
3)Subjects who are contracting kidney and/or liver diseases
4)Those who have been diagnosed with diabetes
5)Individuals with a chronic diseases
6)Person who donated more than 400 ml of blood within 3 months prior to the study
7)Those who can not stop taking a large amount of green tea or black tea during the test period
8)Pregnant women, or women with intending to become pregnant, and lactating woman
9)Individuals participating or intending to participate in a drug administration test
10)Individuals judged by the doctor to be unsuitable
Target sample size 50

Research contact person
Name of lead principal investigator Kazunari Tanaka
Organization Univercity of Nagasaki
Division name Faculty of Nursing and Nutrition
Address 1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195
TEL 095-813-5216
Email katanaka@sun.ac.jp

Public contact
Name of contact person Hideki Ito
Organization Univercity of Nagasaki
Division name Regional Partnership Center
Address 1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195
TEL 095-813-5500
Homepage URL
Email katanaka@sun.ac.jp

Sponsor
Institute Univercity of Nagasaki
Institute
Department

Funding Source
Organization charle Co., Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 09 Month 20 Day

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 09 Month 20 Day
Anticipated trial start date
2017 Year 09 Month 20 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 09 Month 20 Day
Last modified on
2018 Year 03 Month 22 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000033136